title: Infections in oncology: urosepsis due to fluoroquinolone-resistant Escherichia coli after ultrasonographic-guided transrectal implantation of fiducial markers.
authors.affiliation: Division of Infectious Diseases and Tropical Medicine, Moffitt Cancer Center, Tampa, FL 33612, USA.
authors.forename: David D
authors.initials: DD
authors.lastname: Buethe
authors.forename: Wade J
authors.initials: WJ
authors.lastname: Sexton
authors.forename: John N
authors.initials: JN
authors.lastname: Greene
authors.forename: Bhisit
authors.initials: B
authors.lastname: Changcharoen
authors.forename: Pongsathorn
authors.initials: P
authors.lastname: Kue-A-Pai
mesh_terms: D000230:Adenocarcinoma / Q000150:complications / Q000188:drug therapy / Q000382:microbiology / Q000532:radiotherapy; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D024881:Drug Resistance, Bacterial; D004926:Escherichia coli / Q000187:drug effects; D004927:Escherichia coli Infections / Q000150:complications / Q000188:drug therapy / Q000382:microbiology; D057918:Fiducial Markers / Q000009:adverse effects*; D024841:Fluoroquinolones / Q000494:pharmacology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology / Q000532:radiotherapy; D018714:Radiotherapy, Adjuvant; D061089:Radiotherapy, Image-Guided / Q000009:adverse effects*; D018805:Sepsis / Q000188:drug therapy / Q000209:etiology*; D018084:Ultrasonography, Interventional / Q000009:adverse effects*; D014552:Urinary Tract Infections / Q000188:drug therapy / Q000209:etiology*
chemical_list: D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones